Earnings History Data for Bausch + Lomb Corporation (BLCO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Bausch + Lomb Corporation
Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21-02-2024 | PM | BLCO | Bausch + Lomb Corporation | 5,020 | 0.24 | 0.17 | 0.23 | Bausch + Lomb Non-GAAP EPS of $0.24 beats by $0.07, revenue of $1.17B beats by $70M [2/21/2024 6:59 AM] |
16.61 | 2.02 (13.85%) |
16.08 | 1.49 (10.21%) |
13.62 - 21.95 | 1,296,586 | 470,000 | 29,804 | ||
|
||||||||||||||||||
| 01-11-2023 | PM | BLCO | Bausch + Lomb Corporation | 5,720 | 0.22 | 0.18 | 0.31 | Bausch + Lomb Non-GAAP EPS of $0.22 beats by $0.03, revenue of $1B beats by $9.86M [11/1/2023 7:25 AM] |
16.52 | 0.38 (2.35%) |
0.0 | 0.0 (0.00%) |
12.79 - 21.95 | 808,113 | 320,000 | 0 | ||
| 02-08-2023 | PM | BLCO | Bausch + Lomb Corporation | 6,960 | 0.18 | 0.16 | 0.29 | Bausch + Lomb beats Q2 top line estimates, raises FY guidance [8/2/2023 7:29 AM] |
18.95 | -0.40 (-2.07%) |
19.35 | 0.0 (0.00%) |
12.79 - 21.95 | 979,234 | 280,000 | 210 | ||
| 03-05-2023 | PM | 7:00 AM ET (May 3) |
BLCO | Bausch + Lomb Corporation | 6,130 | 0.10 | 0.14 | 0.24 | Bausch + Lomb GAAP EPS of -$0.26 misses by $0.25, revenue of $931M beats by $37.33M [5/3/2023 7:50 AM] |
17.80 | 0.32 (1.80%) |
0.0 | 0.0 (0.00%) |
12.20 - 20.20 | 822,774 | 300,000 | 0 | |
| 22-02-2023 | PM | 7:00 AM ET (Feb 22) |
BLCO | Bausch + Lomb Corporation | 6,530 | 0.23 | 0.22 | 0.00 | Bausch + Lomb Non-GAAP EPS of $0.23 beats by $0.01, revenue of $996M beats by $32.08M [2/22/2023 7:08 AM] |
17.78 | -0.75 (-4.05%) |
0.0 | 0.0 (0.00%) |
12.20 - 20.20 | 894,729 | 690,000 | 0 | |
| 02-11-2022 | PM | 7:00 AM ET (Nov 2) |
BLCO | Bausch + Lomb Corporation | 4,990 | 0.31 | 0.23 | 0.00 | Bausch + Lomb reports Q3 mixed earnings; narrows FY22 guidance range [11/2/2022 7:20 AM] |
13.54 | -0.80 (-5.61%) |
14.52 | 0.17 (1.18%) |
12.20 - 20.20 | 1,065,000 | 0 | 220 | |
|
||||||||||||||||||
| 04-08-2022 | PM | Before the open (Aug 4) |
BLCO | Bausch + Lomb Corporation | 5,370 | 0.29 | 0.20 | 0.00 | Bausch + Lomb Non-GAAP EPS of $0.29 beats by $0.09, revenue of $941M beats by $32.05M [8/4/2022 7:49 AM] |
15.55 | 0.73 (4.93%) |
3.92 | -0.40 (-9.26%) |
12.20 - 20.20 | 2,238,049 | 2,750,000 | 51,552 | |